Literature DB >> 27616290

The effect of regulating molecules on the structure of the PPAR-RXR complex.

Ortal Amber-Vitos1, Navaneet Chaturvedi1, Esther Nachliel1, Menachem Gutman1, Yossi Tsfadia2.   

Abstract

The PPAR-RXR complex is one of the most significant and prevalent regulatory systems, controlling lipid metabolism by gene expression. Both proteins are members of the nuclear hormone receptor family, consisting of a ligand-binding domain (LBD), a hinge and a DNA binding domain (DBD). The two proteins form a heterodimer in the nucleus. The ligand-free complex interacts with corepressor proteins and blocks the expression of the genes. With the activating ligands and coactivator segments of regulating proteins, the heterodimer becomes active and allows translation of the genes under its control. We implemented model-independent all-atom molecular dynamics simulations for clarifying the structure changes that the activating ligand and the regulatory peptides impose on the PPAR-RXR system, starting with an LBD up to the PPAR-RXR-DNA complex. The simulations were carried out first with an active state of the protein. Once the relaxed state was attained, it was transformed into the inactive-state, the resulting structure was simulated. As the complex alternates between the active-inactive conformations, most of the changes are noticed at the junction area between the two subunits, located on the surface of a long fused helical structure made of H10-H11 of the proteins. The significant differences between the states included enhanced rigidity of the inactive complex, enhancement of tight contacts. The main drive for the transformation is the relocation of the tip of H12 of the PPAR that drives the carboxylate of the C-terminal towards the junction between H10-H11 of the RXR, leading to rearrangement of the main contact zone of the proteins.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  All-atom molecular dynamics; Heterodimer-complex; PPAR; RXR; Regulation

Mesh:

Substances:

Year:  2016        PMID: 27616290     DOI: 10.1016/j.bbalip.2016.09.003

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  5 in total

Review 1.  The Opportunities and Challenges of Peroxisome Proliferator-Activated Receptors Ligands in Clinical Drug Discovery and Development.

Authors:  Fan Hong; Pengfei Xu; Yonggong Zhai
Journal:  Int J Mol Sci       Date:  2018-07-27       Impact factor: 5.923

2.  Understanding Calcium-Dependent Conformational Changes in S100A1 Protein: A Combination of Molecular Dynamics and Gene Expression Study in Skeletal Muscle.

Authors:  Navaneet Chaturvedi; Khurshid Ahmad; Brijesh Singh Yadav; Eun Ju Lee; Subash Chandra Sonkar; Ninoslav Marina; Inho Choi
Journal:  Cells       Date:  2020-01-10       Impact factor: 6.600

Review 3.  PPAR-Mediated Toxicology and Applied Pharmacology.

Authors:  Yue Xi; Yunhui Zhang; Sirui Zhu; Yuping Luo; Pengfei Xu; Zhiying Huang
Journal:  Cells       Date:  2020-02-03       Impact factor: 6.600

4.  Extracellular mutation induces an allosteric effect across the membrane and hampers the activity of MRP1 (ABCC1).

Authors:  Yuval Bin Kanner; Assaf Ganoth; Yossi Tsfadia
Journal:  Sci Rep       Date:  2021-06-08       Impact factor: 4.379

5.  Cross-species metabolomic analysis identifies uridine as a potent regeneration promoting factor.

Authors:  Zunpeng Liu; Wei Li; Lingling Geng; Liang Sun; Qiaoran Wang; Yang Yu; Pengze Yan; Chuqian Liang; Jie Ren; Moshi Song; Qian Zhao; Jinghui Lei; Yusheng Cai; Jiaming Li; Kaowen Yan; Zeming Wu; Qun Chu; Jingyi Li; Si Wang; Chunyi Li; Jing-Dong J Han; Reyna Hernandez-Benitez; Ng Shyh-Chang; Juan Carlos Izpisua Belmonte; Weiqi Zhang; Jing Qu; Guang-Hui Liu
Journal:  Cell Discov       Date:  2022-02-01       Impact factor: 38.079

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.